Multiple Sclerosis: all 3,524 studies

Page 27 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.

• High Intensity Interval Training for People With Mild Multiple Sclerosis: A Feasibility StudyCompletedNCT02702804Not applicable
• High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis PatientsCompletedNCT02696590Not applicable
• Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-studyCompletedNCT02695394
• Vibration Training for Preventing Falls in Healthy Population and Multiple SclerosisTerminatedNCT02694666Not applicable
• Task-oriented Upper Limb Training in MSCompletedNCT02688231Not applicable
• TMP001 in Relapsing-remitting Multiple SclerosisCompletedNCT02686788Phase 2
• Tecfidera Diffusion Tensor ImagingCompletedNCT02686684
• Pharmacokinetics of DMF and the Effects of DMF on Exploratory BiomarkersCompletedNCT02683863Phase 4
• Teriflunomide Male Transmission StudyCompletedNCT02679885
• Adderall XR and Cognitive Impairment in MSActive, not recruitingNCT02676739Phase 2/3
• Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MSWithdrawnNCT02675413Phase 4
• Progressive Muscle Relaxation Effect on Sleep Quality, Depression and Stress in People With Multiple SclerosisCompletedNCT02673827Phase 2
• Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple SclerosisCompletedNCT02671682Not applicable
• Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS PatientsCompletedNCT02664623Not applicable
• MSPT Device Usability StudyCompletedNCT02664324
• Aerobic Exercise and Brain Health in Multiple SclerosisCompletedNCT02661555Not applicable
• Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient SatisfactionCompletedNCT02652091
• Evaluation and Neural Basis of Communication in Patients With Multiple SclerosisCompletedNCT02652013Not applicable
• A Pilot Study of Intermittent Calorie Restriction in Multiple SclerosisCompletedNCT02647502Not applicable
• Tecfidera and MRI for Brain Energy in MSTerminatedNCT02644083
• Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm StudyStatus unknownNCT02644044Early Phase 1
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese ParticipantsCompletedNCT02641041Phase 1
• This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-naïve RRMS for ≤ 3 YearsCompletedNCT02638038Phase 2
• Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory ArthritisCompletedNCT02636829Not applicable
• Attention/Working Memory Rehabilitation in Multiple Sclerosis: A Pilot Project Using Cogmed Working Memory TrainingCompletedNCT02634567Not applicable
• Observational Registry of Acthar Gel for Participants With Multiple Sclerosis RelapseCompletedNCT02633033
• Acute Effect of Fascial Mobilization on Gait in Patients With Multiple SclerosisStatus unknownNCT02628834Not applicable
• Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis PatientsCompletedNCT02623946
• A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical TrialCompletedNCT02618902Phase 1
• MRI Guided Focused Ultrasound for Tremor in Multiple SclerosisStatus unknownNCT02614989Not applicable
• An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple SclerosisCompletedNCT02612935
• Efficacy of MBI for Depressive Symptoms in Patients With MSCompletedNCT02611401Not applicable
• Self-Management Program Based on Physical Exercises in People With Multiple SclerosisStatus unknownNCT02607020Not applicable
• [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple SclerosisTerminatedNCT02606630Phase 1
• A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple SclerosisCompletedNCT02601885Phase 1
• Post-transfusion Platelet CountCompletedNCT02601131
• Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis ConditionCompletedNCT02598167
• A RCT of Telephone-supported ACT in MSStatus unknownNCT02596633Phase 3
• Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic BurdenCompletedNCT02592265
• Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?CompletedNCT02588053
• A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMSStatus unknownNCT02587806Phase 1/2
• A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMSStatus unknownNCT02587715Phase 1/2
• A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension PeriodCompletedNCT02587195Phase 3
• A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple SclerosisCompletedNCT02583594Phase 1
• Comprehensive Fall Prevention and Detection in Multiple SclerosisCompletedNCT02583386Not applicable
• Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple SclerosisTerminatedNCT02580669Not applicable
• Deciphering the Role of the Gut Microbiota in Multiple SclerosisStatus unknownNCT02580435
• Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012CompletedNCT02579681Phase 3
• Impacts of Different Training Modes (Intense Versus Ordinary) on the Immune System and Memory Functions in pwMSCompletedNCT02571335Not applicable
• Brimonidine Tartrate for the Treatment of Injection Related ErythemaWithdrawnNCT02568111Phase 4
• Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.CompletedNCT02559765
• Mitochondrial Dysfunction and Disease ProgressionCompletedNCT02549703
• Intrathecal Rituximab in Progressive Multiple SclerosisCompletedNCT02545959Phase 2
• Study of VSN16R for the Treatment of Spasticity in Multiple SclerosisCompletedNCT02542787Phase 2
• Lakeshore Examination of Activity and Disability Exercise Response StudyCompletedNCT02533882Not applicable
• Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)Status unknownNCT02529839Not applicable
• Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive TherapyTerminatedNCT02525367Not applicable
• Influence of Exercise on the Mobility and Balance of Individuals With Multiple SclerosisCompletedNCT02524483Not applicable
• The Impact of Positive Mental Training in Multiple SclerosisCompletedNCT02524093Not applicable
• Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot StudyCompletedNCT02523703Not applicable
• Innovative Physiotherapy and Coordination of Care for People With MS: a RCT and a Qualitative StudyStatus unknownNCT02522962Not applicable
• Single-Dose Study of a New Formulation of BIIB061CompletedNCT02521545Phase 1
• Tecfidera Lymphocyte Chart ReviewCompletedNCT02519413
• Influence of Emotional Disorders and Executive on the Components Retrograde and Anterograde Episodic Memory in MSStatus unknownNCT02518776Not applicable
• Phase I BP Interferon (IFN) Beta-004CompletedNCT02517788Phase 1
• Phase I BP Interferon (IFN) Beta-001CompletedNCT02515695Phase 1
• In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance ImagingCompletedNCT02511028Phase 1
• Normobaric Hypoxic Training and Multiple SclerosisCompletedNCT02509897Not applicable
• WEB-Based Physiotherapy for People With Multiple SclerosisCompletedNCT02508961Not applicable
• Open-label Study of Liothyronine in MSCompletedNCT02506751Phase 1
• Natural History of Multiple Sclerosis and Its MimickersCompletedNCT02504840
• Comparison of Two Physical Activity Interventions in Individuals With Multiple SclerosisStatus unknownNCT02496416Not applicable
• Autologous Mesenchymal Stromal Cells for Multiple SclerosisCompletedNCT02495766Phase 1/2
• Dual Task Cost in the Upper Limb in Persons With Multiple SclerosisCompletedNCT02493166Not applicable
• Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)CompletedNCT02493049Phase 2
• Teriflunomide Observational Effectiveness StudyCompletedNCT02490982
• A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MSCompletedNCT02490943Not applicable
• D-mannose for the Prevention of UTIs in Multiple SclerosisStatus unknownNCT02490046Phase 1
• Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and HerpesvirusStatus unknownNCT02489877
• Profile of Adherence to Therapy and Interventions to Promote Adherence in MSStatus unknownNCT02488343Not applicable
• Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With BetaferonCompletedNCT02486640
• Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple SclerosisStatus unknownNCT02485223
• Baseline Cortical Haemodynamics in MSStatus unknownNCT02481882Not applicable
• MS Symptom Management StudyCompletedNCT02474940Not applicable
• Comparison Study of PF530 and Betaferon in Healthy SubjectsCompletedNCT02474134Phase 1
• Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple SclerosisWithdrawnNCT02472938Phase 4
• Tecfidera and the Gut MicrobiotaCompletedNCT02471560Phase 4
• Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking ImpairmentCompletedNCT02471222Phase 2
• Depression and Facial Identity Recognition Abilities in Patients With Multiple SclerosisCompletedNCT02468765
• Treatment of Pendular Nystagmus in OPTCompletedNCT02466191Phase 4
• Multiple Sclerosis: Associated Cardiometabolic Risks and Impact of Exercise TherapyCompletedNCT02466165Not applicable
• The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy SubjectsCompletedNCT02463318Not applicable
• Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple SclerosisCompletedNCT02461069Phase 4
• Effects of GE-O System on Gait Impairments in Multiple Sclerosis SubjectsStatus unknownNCT02459821Not applicable
• Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MSCompletedNCT02457091Phase 2
• The Use of Technology to Improve MS Clinical Trials and Patient CareCompletedNCT02454907Not applicable
• Evaluation of an Acceptance and Commitment Therapy Group for Adjustment Difficulties in Neurological ConditionsCompletedNCT02454465Not applicable
• A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple SclerosisCompletedNCT02442570Phase 2
• Safety and Dose-finding Study of DC-TAB in Healthy SubjectsCompletedNCT02442557Phase 1
• Standardized Ambulatory Neurorehabilitation Program for Patients With Multiple SclerosisCompletedNCT02440516Not applicable

← Multiple Sclerosis overview